No Detail Found!

Effects of Autologous Bone Marrow Derived Stem Cell Transplant and Exercise Training Program on Rheumatoid Arthritis.

Author(s)
Syed Salman Naeem Gilani Department of Stem Cell, Al Sayed Hospital, Rawalpindi, Pakistan
Muhammad Naeem Department of Physiotherapy, Al Sayed Hospital, Rawalpindi, Pakistan
Tauseef Bukhari Al Sayed Hospital, Rawalpindi, Pakistan
Muhammad Asad Ullah Department of Physiotherapy, Stem Cell Al Sayed Hospital, Rawalpindi, Pakistan
Abstract
A 65 year old female patient suffering from Rheumatoid Arthritis reported with multiple joint pains, malaise, fatigue, difficulty in breathing, difficulty in opening Jaw, difficulty in holding objects and menopausal symptoms. She had been taking multiple medications including Indomethacin, Aspirin, Prednisolone, Methotrexate etc. Treatment at Al-Sayed Hospital Rawalpindi included autologous bone marrow derived stem cell transplantation and exercise training program. Specific exercises were given four weeks before and eight weeks after stem cell transplant at our center. After one year of treatment, the patient had improvement in all of her signs and symptoms, which enabled her to discontinue several medications. There was marked improvement in her joint pain, range of motion, muscle power, grip function, functional activities and Activities of Daily Living (ADLs).
Publication Details
Page(s) 157-159
DOI DOI not available
Published Journal: Journal of Islamic International Medical College, Volume: 12, Issue: 3, Year: 2017

Request the full text from PASTIC

References
TugwellP,PincusT,YocumD,SteinM,GluckO,KraagG, 1995.Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis,New England Journal of Medicine 333 137 -42
de PunderYM,HendrikxJ,den BroederAA,PascualEV,van RielPL,FransenJ, 2013.Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative,The Journal of rheumatology 40 1268 -74
Van NiesJA,KrabbenA,SchoonesJW,HuizingaTW,KloppenburgM,van der,MilAH, 2014.What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review,Annals of the rheumatic diseases 73 861 -70
SmolenJS,LandewéR,BreedveldFC,DougadosM,EmeryP,Gaujoux-VialaC, 2010.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs,Annals of the rheumatic diseases 69 964 -75
MainiR,St ClairEW,BreedveldF,FurstD,KaldenJ,WeismanM, 1999.Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial,Lancet 354 1932 -9
SnowdenJA,BrooksPM,BiggsJC, 1997.Haemopoietic stem cell transplantation for autoimmune diseases,British journal of haematology 99 9 -22
WangY,ChenX,CaoW,ShiY., 2014.Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications,Nature immunology 15 1009 -16
BouffiC,BonyC,CourtiesG,JorgensenC, 2010.- dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis,PloS one 5 e14247 -
SnowdenJA,BiggsJC,MillikenST,FullerA,StaniforthD,PassuelloF, 1998.A randomised, blinded, placebocontrolled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis,Bone marrow transplantation 22 1035 -41
MooreJ,BrooksP,MillikenS,BiggsJ,MaD,HandelM, 2002.A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis,Arthritis & Rheumatism 46 2301 -9
0

Citations

0

Downloads

64

Views